Agid France
Direction de la Recherche, Ministère de la Recherche et des Nouvelles Technologies, 1, rue Descartes, 75231 Paris cedex 05.
J Soc Biol. 2004;198(3):207-11.
The French Ministry in charge of Research has launched a multi-institutional incentive concerted action to assist Southern countries on malaria: the PAL+ program. PAL+ aims at bringing out: 1) conditions to promote novel preventive and therapeutic tools adapted to existing situations in the countries concerned; 2) a contribution to help research teams in Southern countries become competitive. PAL+ plans to strengthen cooperative relationships with developing countries (subsaharian Africa, South East Asia and South American countries). Research programs were oriented towards public health needs in malaria-endemic countries and thus mainly focused on: i) development of new antimalarial drugs and new therapeutical strategies: new targets and new leads for drugs, clinical assays for recognition of malaria and optimization of effective treatment or prophylactic drug dosage; ii) pathophysiology of severe malaria: mechanisms of immunity, biology and genome of host and parasite and research leading to vaccine trials; iii) basic and field research on mosquito genetics and biology which may lead to new prevention and control opportunities; iv) social studies on behaviours and habits around prevention and medication of malaria. The objective is to help Southern countries increase their capacity in clinical research, epidemiology, therapeutics, public health and social science (e.g. behaviours and habits accompanying medicine-taking). This means a true partnership and training adapted to specific needs and based on sound science. Research was therefore largely pursued in the laboratories of Southern countries and PAL+ supported the initiative in different ways by: i) providing easier opportunities for scientists from the North to collaborate with scientists from the South; ii) supporting networks of scientist collaborations. This was achieved by setting up a new type of relationships between scientists, based on a continuous dialogue and on bringing them together in small meetings on thematic discussions, the so-called Ateliers de PAL+. The Ateliers should play a major role in increasing the scientific capacity in developing countries. PAL+ program is a commitment to speed up better understanding of the disease by helping endemic countries contribute to research for their own benefit.
法国负责研究的部门发起了一项多机构联合激励行动,以协助南方国家抗击疟疾:即PAL+项目。PAL+旨在实现以下目标:1)创造条件,推广适用于相关国家现有情况的新型预防和治疗工具;2)助力南方国家的研究团队提升竞争力。PAL+计划加强与发展中国家(撒哈拉以南非洲、东南亚和南美国家)的合作关系。研究项目围绕疟疾流行国家的公共卫生需求展开,主要聚焦于:i)新型抗疟药物和新治疗策略的研发:药物的新靶点和新先导化合物、疟疾识别的临床检测以及有效治疗或预防药物剂量的优化;ii)重症疟疾的病理生理学:免疫机制、宿主和寄生虫的生物学及基因组,以及通向疫苗试验的研究;iii)蚊子遗传学和生物学的基础及实地研究,这可能带来新的预防和控制机会;iv)关于疟疾预防和用药方面行为及习惯的社会研究。目标是帮助南方国家提高其在临床研究、流行病学、治疗学、公共卫生和社会科学(如服药相关行为及习惯)方面的能力。这意味着建立一种真正基于合理科学、适应特定需求的伙伴关系和培训模式。因此,大部分研究在南方国家的实验室进行,PAL+通过以下不同方式支持相关举措:i)为北方科学家与南方科学家的合作提供更便利的机会;ii)支持科学家合作网络。这是通过在科学家之间建立一种新型关系来实现的,这种关系基于持续对话,并通过小型专题讨论会议(即所谓的PAL+研讨会)将他们聚集在一起。这些研讨会应在提高发展中国家的科研能力方面发挥重要作用。PAL+项目致力于通过帮助疟疾流行国家开展有利于自身的研究,加快对该疾病的深入了解。